Graft rejection and graft-versus-host disease: mirror images
- PMID: 2873281
- DOI: 10.1016/s0140-6736(86)91503-5
Graft rejection and graft-versus-host disease: mirror images
Abstract
Graft rejection and graft-versus-host disease (GvHD) complicate bone marrow transplantation in animals and man. The likelihood of each correlates with the degree of genetic disparity between donor and recipient. However, instead of a direct relation between graft rejection and GvHD, these events are inversely correlated: in most instances, they are mutually exclusive. A similar, complex relation exists with a third possible event, graft-versus-leukaemia. Attempts to suppress graft rejection or GvHD are likely to increase the reciprocal outcomes unless additional measures are instituted.
Similar articles
-
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7. Biol Blood Marrow Transplant. 1997. PMID: 9209736
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Mechanisms of graft failure after human marrow transplantation: a review.Immunol Lett. 1991 Jul;29(1-2):77-80. doi: 10.1016/0165-2478(91)90204-n. Immunol Lett. 1991. PMID: 1916930 Review.
-
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.J Hematother. 1994 Spring;3(1):15-31. doi: 10.1089/scd.1.1994.3.15. J Hematother. 1994. PMID: 7922004 Clinical Trial.
-
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.Bone Marrow Transplant. 1994 May;13(5):597-611. Bone Marrow Transplant. 1994. PMID: 8054913
Cited by
-
Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway.Blood. 2008 Dec 1;112(12):4765-75. doi: 10.1182/blood-2008-05-154278. Epub 2008 Jul 14. Blood. 2008. PMID: 18625883 Free PMC article.
-
The lost chord: microchimerism and allograft survival.Immunol Today. 1996 Dec;17(12):577-84; discussion 588. doi: 10.1016/s0167-5699(96)10070-0. Immunol Today. 1996. PMID: 8991290 Free PMC article. Review.
-
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment.Stem Cells Int. 2016;2016:9025835. doi: 10.1155/2016/9025835. Epub 2016 Jan 5. Stem Cells Int. 2016. PMID: 26880996 Free PMC article. Review.
-
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.J Exp Med. 1988 Feb 1;167(2):556-69. doi: 10.1084/jem.167.2.556. J Exp Med. 1988. PMID: 2964497 Free PMC article.
-
A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells.Blood. 2013 Apr 11;121(15):3033-40. doi: 10.1182/blood-2012-06-432443. Epub 2013 Feb 27. Blood. 2013. PMID: 23446736 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical